These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 39028267)

  • 1. Cyclometalated iridium(III) tetrazine complexes for mitochondria-targeted two-photon photodynamic therapy.
    Tan Z; Lin M; Liu J; Wu H; Chao H
    Dalton Trans; 2024 Aug; 53(31):12917-12926. PubMed ID: 39028267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands.
    Sanz-Villafruela J; Bermejo-Casadesus C; Zafon E; Martínez-Alonso M; Durá G; Heras A; Soriano-Díaz I; Giussani A; Ortí E; Tebar F; Espino G; Massaguer A
    Eur J Med Chem; 2024 Oct; 276():116618. PubMed ID: 38972079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclometalated iridium(iii) complexes for mitochondria-targeted combined chemo-photodynamic therapy.
    Qin WW; Pan ZY; Cai DH; Li Y; He L
    Dalton Trans; 2020 Mar; 49(11):3562-3569. PubMed ID: 32123890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer activity and mechanism studies of photoactivated iridium(III) complexes toward lung cancer A549 cells.
    Zhou L; Li J; Chen J; Yao X; Zeng X; Liu Y; Wang Y; Wang X
    Dalton Trans; 2024 Sep; 53(36):15176-15189. PubMed ID: 39221457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, photophysical and anticancer properties of mitochondria-targeted phosphorescent cyclometalated iridium(III) N-heterocyclic carbene complexes.
    Li Y; Wang KN; He L; Ji LN; Mao ZW
    J Inorg Biochem; 2020 Apr; 205():110976. PubMed ID: 31926377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
    Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
    J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
    Song XD; Chen BB; He SF; Pan NL; Liao JX; Chen JX; Wang GH; Sun J
    Eur J Med Chem; 2019 Oct; 179():26-37. PubMed ID: 31233920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclometalated Iridium(III) Complexes as High-Sensitivity Two-Photon Excited Mitochondria Dyes and Near-Infrared Photodynamic Therapy Agents.
    Bi XD; Yang R; Zhou YC; Chen D; Li GK; Guo YX; Wang MF; Liu D; Gao F
    Inorg Chem; 2020 Oct; 59(20):14920-14931. PubMed ID: 32951429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-wavelength triggered iridium(III) complex nanoparticles for photodynamic therapy against hypoxic cancer.
    Liu S; Wang Z; Wu Z; Chen H; Zhu D; Li G; Yan M; Bryce MR; Chang Y
    Chem Commun (Camb); 2024 Sep; 60(73):9938-9941. PubMed ID: 39171567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of pH-responsive cyclometalated iridium(III) complex and its application in the selective killing of cancerous cells.
    Yang P; Zhang S; Wang K; Qi H
    Dalton Trans; 2021 Nov; 50(46):17338-17345. PubMed ID: 34788356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray tomography of cryopreserved human prostate cancer cells: mitochondrial targeting by an organoiridium photosensitiser.
    Bolitho EM; Sanchez-Cano C; Huang H; Hands-Portman I; Spink M; Quinn PD; Harkiolaki M; Sadler PJ
    J Biol Inorg Chem; 2020 Mar; 25(2):295-303. PubMed ID: 32124100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bombesin-Targeted Delivery of β-Carboline-Based Ir(III) and Ru(II) Photosensitizers for a Selective Photodynamic Therapy of Prostate Cancer.
    Sanz-Villafruela J; Bermejo-Casadesús C; Riesco-Llach G; Iglesias M; Martínez-Alonso M; Planas M; Feliu L; Espino G; Massaguer A
    Inorg Chem; 2024 Oct; 63(41):19140-19155. PubMed ID: 39361042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells.
    Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H
    Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
    Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chiral Iridium-Based TLD-1433 Analogues: Exploration of Enantiomer-Dependent Behavior in Photodynamic Cancer Therapy.
    Wang W; Wang L; Zhang Y; Shi Y; Zhang R; Chen L; Shi Z; Yuan S; Li X; He C; Li X
    Inorg Chem; 2024 Apr; 63(17):7792-7798. PubMed ID: 38619892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Mitochondria-Targeted Photosensitizer Showing Improved Photodynamic Therapy Effects Under Hypoxia.
    Lv W; Zhang Z; Zhang KY; Yang H; Liu S; Xu A; Guo S; Zhao Q; Huang W
    Angew Chem Int Ed Engl; 2016 Aug; 55(34):9947-51. PubMed ID: 27381490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand Dictated Photosensitization of Iridium(III) Dithiocarbamate Complexes for Photodynamic Therapy.
    Negi M; Dixit T; Venkatesh V
    Inorg Chem; 2023 Dec; 62(49):20080-20095. PubMed ID: 37994001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mitochondrion-targeted BODIPY-Ir(III) conjugate as a photoinduced ROS generator for the oxidative destruction of triple-negative breast cancer cells.
    Qiao L; Liu J; Kuang S; Liao X; Kou J; Ji L; Chao H
    Dalton Trans; 2021 Oct; 50(40):14332-14341. PubMed ID: 34558567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-Chemiluminescence-Triggered Ir(III) Complex Photosensitizer for Photodynamic Therapy against Hypoxic Tumor.
    Liu S; Chen H; Wu Q; Sun Y; Pei Y; Wang Z; Zhu D; Li G; Bryce MR; Chang Y
    Inorg Chem; 2024 Sep; 63(35):16404-16417. PubMed ID: 39150967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards efficient Ir(III) anticancer photodynamic therapy agents by extending π-conjugation on N^N ligands.
    Sanz-Villafruela J; Bermejo-Casadesús C; Martínez-Alonso M; Moro A; Lima JC; Massaguer A; Espino G
    Dalton Trans; 2024 Jul; 53(27):11393-11409. PubMed ID: 38899369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.